Lixisenatide
Especificaciones
320367-13-3Número CAS
685-146-9Número CE
(4S)-5-[[2-[[(2S,3R)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2Nombre IUPAC
C215H347N61O65SFórmula química
4858 g/molPeso molecular
Lixisenatide; Adlyxin; Lyxumia; ZP10A peptide; 320367-13-3; ZP 10; AVE0010; AQVE-10010; AVE 0010; lixisenatida; lixisenatidum; AVE 010; AVE-010; ZP-10; AVE-0010; Des-38-proline-exendine-4 (Heloderma suspectum)-(1-39)-peptidylpenta-L-lysyl-L-lysinamide; CHEBI:85662; 74O62BB01U; DesPro38Exendin-4(1-39)-Lys6-NH2; RefChem:391; A10BJ03; DTXSID301029581; SOLIQUA 100/33 COMPONENT LIXISENATIDE; Lixisenatide [USAN:INN]; UNII-74O62BB01U; H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH2; Lixisenatide?; DesPro36Exendin-4(1-39)-Lys6-NH2; SCHEMBL29429438; GLXC-22545; FL76758; AC-38402; G13830; H-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK-NH2; H-L-His-Gly-L-Glu-Gly-L-Thr-L-Phe-L-Thr-L-Ser-L-Asp-L-Leu-L-Ser-L-Lys-L-Gln-L-Met-L-Glu-L-Glu-L-Glu-L-Ala-L-Val-L-Arg-L-Leu-L-Phe-L-Ile-L-Glu-L-Trp-L-Leu-L-Lys-L-Asn-Gly-Gly-L-Pro-L-Ser-L-Ser-Gly-L-Ala-L-Pro-L-Pro-L-Ser-L-Lys-L-Lys-L-Lys-L-Lys-L-Lys-L-Lys-NH2Sinónimos
Productos que contienen Lixisenatide
솔리쿠아펜주(10-40)솔리쿠아펜주(30-60)SULIQUA 100 UNIDADES/ML + 50 MICROGRAMOS/ML SOLUCION INYECTABLE EN PLUMA PRECARGADASULIQUA 100 UNIDADES/ML + 33 MICROGRAMOS/ML SOLUCION INYECTABLE EN PLUMA PRECARGADALYXUMIA 20 MICROGRAMOS SOLUCION INYECTABLELYXUMIA 10 MICROGRAMOS SOLUCION INYECTABLELYXUMIA 10 MICROGRAMOS + 20 MICROGRAMOS SOLUCION INYECTABLESoliqua SolostarSoliqua SolostarLixisenatidumLixisenatideLixisenatide
Página 1 de 2
